Panacor is focused on the development and commercialization of new drug products.
The company’s lead product, Nephoxil®, is in the final stage of clinical development and expects to file the NDA in 2012...more
What's New
Panacor to present at Cowen 32nd Annual Health Care Conference…more
NEPHOXIL® PIII study is near completion with an NDA filing expected in 2H 2012...more
Business Collaboration
Please direct all requests for information and other inquiries to: info@panacorbio.com...more
R & D
Panacor has built a significant product pipeline, promising the sustainable growth...more
2012 Panacor Bioscience Ltd. (PANACOR™) All Rights Reserved.
